{
  "docId": "019dd923-5efe-75c0-8dff-2e87a7b85930",
  "docSlug": "d74f6dfc5c764997",
  "documentTitle": "2026 Capital Markets Day AM",
  "authorId": "Syncona",
  "authorName": "Syncona",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.778,
  "pageNumber": 47,
  "pageCount": 55,
  "prevPage": 46,
  "nextPage": 48,
  "slideType": "initiative_list",
  "function": "size_opportunity",
  "density": "dense",
  "nDataPoints": 8,
  "notes": "The slide uses a structured grid to categorize portfolio companies by their development stage and market potential.",
  "elementsJson": [
    "headline_text",
    "subtitle_text",
    "comparison_table",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5efe-75c0-8dff-2e87a7b85930/47",
  "deckHref": "/decks/019dd923-5efe-75c0-8dff-2e87a7b85930",
  "deckJsonHref": "/decks/019dd923-5efe-75c0-8dff-2e87a7b85930.json",
  "deckAnchorHref": "/decks/019dd923-5efe-75c0-8dff-2e87a7b85930#slide-47",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Supporting the return of a minimum of £250 million to shareholders from private company exits",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-832d-736c-a658-d21ab00d5e57",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.94,
        "x": 0.03,
        "y": 0.25
      },
      "kind": "list",
      "text": "Portfolio company details including Autolus, Beacon Therapeutics, SPUR, and Ionctura with their respective KVIP timelines, clinical status, ownership stakes, and market sizing metrics.",
      "attrs": null,
      "subkind": "comparison",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4d2ccc0b-9fad-42d3-be65-ddd7038aa0e5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "NAV growth: £250 million",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-832d-736c-a658-d69469c0173c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.3,
        "x": 0.03,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "1. Fully diluted ownership stakes at 31 December 2025. Source: Based on Syncona market view.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a47194be-402a-4ccb-936d-30bde44b9a30",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.8,
        "x": 0.03,
        "y": 0.12
      },
      "kind": "title",
      "text": "Supporting the return of a minimum of £250 million to shareholders from private company exits",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8ebd48f9-f03e-4909-85a8-5d3186079be0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.65,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "title",
      "text": "KVIPs have the potential to deliver significant NAV growth",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "94b4cee9-a421-4cd3-859f-b201847bcd54",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "c9675bc6-756d-412c-9673-2ccba846b071",
      "evidence": "list/comparison: Portfolio company details including Autolus, Beacon Therapeutics, SPUR, and Ionctura with their respective KVIP timelines, clinical status, ownership stakes, and market sizing metrics.",
      "confidence": 0.9
    }
  ],
  "frameworks": [
    {
      "name": "list-presentation",
      "slug": null,
      "matchId": "fde2887b-ab36-4814-8ed8-2741afbd38a1",
      "evidence": "Structured grid layout for comparing portfolio companies",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}